Skip to main content
Log in

Best Practices for Submitting Promotional 2253 Submissions in the New Module 1 Specification

  • Regulatory Science: Original Research
  • Published:
Therapeutic Innovation & Regulatory Science Aims and scope Submit manuscript

Abstract

June 2016 marks 1 full year since the optional implementation of US Module 1 Specification v2.3. Since its release, pharma companies have dealt with expanded submission-level metadata fields, the ability to submit advertising and promotional submissions, and more rigid validation criteria. Prior to transitioning, sponsors must ensure their building and validating tools are up-to-date, that a system is in place to integrate departments working together for the first time, and that all guidance documents are understood and implemented. Sponsors now can group submissions across application types, which will help save rework across submissions. Looking at one submission type now accepted in eCTD, this paper will explore the new functionality that has created new possibilities and challenges for Regulatory Operations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. eCTD backbone files specification for module 1. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM163552.pdf. Accessed July 1, 2016.

  2. Comprehensive table of contents headings and hierarchies, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM163175.pdf. Accessed June 29, 2016.

  3. Draft guidance: Providing regulatory submissions in electronic and non-electronic format—promotional labeling and advertising materials for human prescription drugs. Guidance for industry. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM443702.pdf. Accessed June 20, 2016.

  4. File formats. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM347471.pdf. Accessed June 25, 2016.

  5. E-signing. http://www.fda.gov/forindustry/electronicsubmissionsgateway/ucm113223.htm. Accessed July 28, 2016.

  6. Specifications for eCTD validation criteria. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM366165.pdf. Accessed July 27, 2016.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandra Krogulski.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krogulski, S. Best Practices for Submitting Promotional 2253 Submissions in the New Module 1 Specification. Ther Innov Regul Sci 51, 645–650 (2017). https://doi.org/10.1177/2168479017702185

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/2168479017702185

Keywords

Navigation